Noninfectious Inflammatory Response following Intravitreal Bevacizumab Injections: Description of a Cluster of Cases in Two Centers and a Review of the Literature
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Purpose: To report a cluster of high incidence of noninfectious inflammatory reaction shortly after bevacizumab injection. Methods: Data were collected from medical records of consecutive patients who underwent bevacizumab injections and presented with acute uveitis within 1–4 days. Results: All 7 patients were injected intravitreally with bevacizumab from different batches and presented with visual deterioration. One patient with anterior uveitis complained of pain. None had hypopyon. Three patients with vitritis underwent a vitreous tap with an intravitreal injection of vancomycin and ceftazidime for possible infectious endophthalmitis. All patients received intensive topical antibiotic drops and steroids, and the intraocular inflammation resolved completely within 1 month. Five patients continued to receive bevacizumab injections without recurrent episodes. Conclusions: Our series demonstrates an incidence of noninfectious inflammatory reaction shortly after bevacizumab injection that is higher than that reported in the literature. The cause is more likely the preparation process in the same compounding pharmacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systemic or periocular steroids are rarely utilized [2, 11, 14, 23, 24].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [24]
Citations
Cites
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Intravitreal Aflibercept for Diabetic Macular Edema
Heier, J. S., Korobelnik, J.-F., Brown, D. M., Schmidt-Erfurth, U., Do, D. V., Midena, E., Boyer, D. S., Terasaki, H., Kaiser, P. K., Marcus, D. M., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.07.032 · Cited by 429
Georgopoulos, M., Polak, K., Prager, F., Prunte, C., & Schmidt-Erfurth, U. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.138479 · Cited by 124
Thach, A. B., Yau, L., Hoang, C., & Tuomi, L. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.022 · Cited by 98
Meredith, T. A., McCannel, C. A., Barr, C., Doft, B. H., Peskin, E., Maguire, M. G., Martin, D. F., & Prenner, J. L. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.10.027 · Cited by 84
Complications of Intravitreal Injections in Patients with Diabetes
Shikari, H., Silva, P. S., & Sun, J. K. (2014) · Seminars in Ophthalmology · doi:10.3109/08820538.2014.962167 · Cited by 73
Williams, P. D., Chong, D., Fuller, T., & Callanan, D. (2016) · Retina · doi:10.1097/iae.0000000000000801 · Cited by 69
Kitchens, J. W., Diana, V., Boyer, D. S., Thompson, D. E., Gibson, A., Saroj, N., Vitti, R., Berliner, A. J., & Kaiser, P. K. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.046 · Cited by 68
Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
Bressler, N. M., Varma, R., Suñer, I. J., Dolan, C., Ward, J., Ehrlich, J. S., Colman, S. S., & Turpcu, A. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.008 · Cited by 60
Nuzzi, R., & Tridico, F. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.835833 · Cited by 38
Uveitis Following Intravitreal Bevacizumab: A Non-Infectious Cluster
Kay, C. N., Tarantola, R. M., Gehrs, K. M., Folk, J. C., Mahajan, V. B., Boldt, H. C., Syed, N. A., & Russell, S. R. (2011) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/15428877-20110603-04 · Cited by 37
Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab
Mozayan, A., & Farah, S. (2013) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/23258160-20121221-08 · Cited by 22
Cited by
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00307-7 · Cited by 155
Issues with Intravitreal Administration of Anti-VEGF Drugs
Schargus, M., & Фрингс, А. (2020) · Clinical ophthalmology · doi:10.2147/opth.s207978 · Cited by 62
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Khoramnia, R., Figueroa, M. S., Kuhli-Hattenbach, C., Pavesio, C. E., Anderesi, M., Schmouder, R., Chen, Y., & de Smet, M. D. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05518-0 · Cited by 25
Whiting, R. E. H., Pearce, J. W., Vansteenkiste, D. P., Bibi, K. F., Lim, S., Kick, G. R., Castaner, L. J., Sinclair, J., Chandra, S. A. M., Nguyen, A., et al. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108130 · Cited by 22
Jang, K., Ahn, J., Sohn, J., & Hwang, D. D.-J. (2020) · Clinical ophthalmology · doi:10.2147/opth.s276620 · Cited by 11
Metadata
- Authors
- Trivizki, O., Schwartz, S., Negri, N., Loewenstein, A., Rabina, G., & Shulman, S.
- Affiliations
- Tel Aviv University (IL)
- Venue
- Ophthalmologica
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 240
- Issue
- 3
- Pages
- 163-166
- ISSN
- 0030-3755 (ISSN-L)
- 1423-0267
- OpenAlex
- W2888854458
- Cited by
- 11
- References
- 14
- Citations by year
- 2025: 1 · 2024: 1 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 1
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Ophthalmologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- bevacizumab, intravitreal injection, non-infectious uveitis, acute uveitis, vitritis, anterior uveitis, drug-induced inflammation, compounding pharmacies, adverse drug reactions, vancomycin, ceftazidime
- MeSH terms
- Bevacizumab, Acute Disease, Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, Humans, Inflammation, Macular Degeneration, Male, Ophthalmic Solutions, Retinal Vein Occlusion, Uveitis, Incidence, Cluster Analysis, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Intravitreal Injections, Administration, Ophthalmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.